Targeting the mTOR pathway in breast cancer
Mechanistic target of rapamycin controls cell growth, metabolism, and aging in response to nutrients, cellular energy stage, and growth factors. In cancers including breast cancer, mechanistic target of rapamycin is frequently upregulated. Blocking mechanistic target of rapamycin with rapamycin, fir...
Saved in:
| Main Authors: | Jia Liu, Hui-Qing Li, Fu-Xia Zhou, Jie-Wen Yu, Ling Sun, Zhong-Hou Han |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-06-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317710825 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node
by: Laura Mantoan Ritter, et al.
Published: (2025-05-01) -
Orthoflavivirus infection and the mTOR signaling pathway
by: Yahui Zhang, et al.
Published: (2025-04-01) -
Targeting mTOR pathway: A new concept in cancer therapy
by: Advani S
Published: (2010-12-01) -
Targeting the mTOR Pathway in Hepatocellular Carcinoma: The Therapeutic Potential of Natural Products
by: Chen G, et al.
Published: (2024-12-01) -
mTOR inhibition in management of advanced breast cancer
by: Shona Nag
Published: (2012-01-01)